Aug 2026· International Conference Computational Vision and Bio Inspired Computing· pp. 507-513· 0 citations· 23 references
Abstract
Alzheimer's disease is a progressive neurodegenerative disease that leads to memory loss, cognitive decline and brain atrophy. Mild Cognitive Impairment is the early transitional stage between normal ageing and Alzheimer's disease in which brain structural changes start to appear but daily life functioning is still preserved. Early and accurate detection of MCI from brain MRI is clinically hard due to the subtle signal, about 1-3% per year hippocampal volume loss and cortical thinning, which cannot be reliably identified by an human expert. In this work, we propose a deep learning pipeline to first apply HD-BET to skull strip T1-weighted 3D MRI volumes from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset and retain only brain tissue information, then crop out 2D slices in the central brain region in 3 anatomical planes, and further train a fine-tuned ResNet50 on these slices for binary classification of cognitively normal (CN) subjects vs MCI subjects. The system reaches balanced accuracy of $\mathbf{8 3. 3 5 \%}$, AUC-ROC of $\mathbf{9 1. 3 0 \%}$. Gradientweighted Class Activation Mapping visualisations show that model attention spatially aligns with hippocampal and temporal lobe regions, which are the main anatomical biomarkers of early MCI, making the predictions interpretable by humans.
Alzheimer’s Disease (AD) is a progressive neurological disorder that impairs cognitive functions, severely affecting patients’ quality of life. Thus, early and accurate diagnosis is essential to provide a chance for treatment. This paper proposes two deep learning (DL) models to enable automated diagnosis of medical im...
Sarah Oraby, Ahmed Emran, Basel El-Saghir et al.· Scientific Reports· 0 citations
An advanced DL-powered framework for the early prediction of AD using MRI data demonstrates high accuracy, robustness, and interpretability, supporting its potential for reliable early AD diagnosis in clinical settings.
K. V. S. V. Trinadh Reddy, G. Srinivasalu, T. V. Rao et al.· Archives of Medical Research· 0 citations
Alzheimer’s disease (AD) accounts for 60–70% of dementia cases, with mild cognitive impairment (MCI) as a prodromal stage. Early diagnosis is critical. This study aimed to develop and validate a lightweight deep learning pipeline for automated classification of AD, MCI, and cognitively normal (CN) using routine 1.5 T M...
Z. Hasankhani, Gelareh Valizadeh, Davoud Khezerloo et al.· The Egyptian Journal of Radi...· 0 citations
Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...
Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al.· IISE Annual Conference &...· 1 citation
The findings suggest that combining attention-augmented segmentation with transfer learning-based classification can effectively support automated AD detection from structural MRI, potentially reducing the manual burden on clinicians.
Nirupama Panabakam, K. Elangovan, Koteeswaran Seerangan et al.· Frontiers in Neuroscience· 0 citations